Subscribe to the newsletter

Publications

Latest publications

Load previous publications
  • November 1, 2013

    Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly.

    Capo-Chichi JM, Tcherkezian J, Hamdan FF, Décarie JC, Dobrzeniecka S, Patry L, Nadon MA, Mucha BE, Major P, Shevell M, Bencheikh BO, Joober R, Samuels ME, Rouleau GA, Roux PP, Michaud JL
    J. Med. Genet. 2013-11-01 ;50( 11 ):740-4

  • November 1, 2013

    Funding considerations for the disclosure of genetic incidental findings in biobank research.

    Black L, Avard D, Zawati M, Knoppers B, Hébert J, Sauvageau G,
    Clin. Genet. 2013-11-01 ;84( 5 ):397-406

  • October 31, 2013

    Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice.

    Cheung AM, Nguyen LV, Carles A, Beer P, Miller PH, Knapp D, Dhillon K, Hirst M, Eaves CJ
    Blood 2013-10-31 ;122( 18 ):3129-37

  • October 25, 2013

    Insulin Activates RSK (p90 Ribosomal S6 Kinase) to Trigger a New Negative Feedback Loop That Regulates Insulin Signaling for Glucose Metabolism.

    Smadja-Lamère N, Shum M, Déléris P, Roux PP, Abe J, Marette A
    J. Biol. Chem. 2013-10-25 ;288( 43 ):31165-76

  • October 7, 2013

    Rapamycin Resistance: mTORC1 Substrates Hold Some of the Answers.

    Yoon SO, Roux PP
    Curr. Biol. 2013-10-07 ;23( 19 ):R880-3

  • October 4, 2013

    A comparative CEST NMR study of slow conformational dynamics of small GTPases complexed with GTP and GTP analogues.

    Long D, Marshall CB, Bouvignies G, Mazhab-Jafari MT, Smith M, Ikura M, Kay LE
    Angew. Chem. Int. Ed. Engl. 2013-10-04 ;52( 41 ):10771-4

  • October 1, 2013

    The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.

    Hariri F, Arguello M, Volpon L, Culjkovic-Kraljacic B, Nielsen TH, Hiscott J, Mann KK, Borden K
    Leukemia 2013-10-01 ;27( 10 ):2047-55

  • September 19, 2013

    RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.

    Ray-David H, Romeo Y, Lavoie G, Déléris P, Tcherkezian J, Galan JA, Roux PP
    Oncogene 2013-09-19 ;32( 38 ):4480-9

Load more publications